Common Sensing, a company that has developed a smart connected insulin pen cap, has partnered with Welkin Health, a San Francisco-based digital health company, to offer a new program designed to improve insulin adherence for people managing diabetes.
“A first-of-its-kind initiative, the program will combine insulin dosing data, wirelessly transmitted from Common Sensing’s Gocap, real-time blood glucose data, and data gleaned from Welkin Health coaches who will work closely to support patients in the context of their daily lives,” reads a provided statement from the company.
The ability to monitor patient data and behaviors as they occur will equip care teams with a holistic view of each patient’s diabetes profile, enabling them to significantly impact the outcomes of people managing diabetes like never before.
“The program we’re developing with Welkin will provide a critical element that is missing from home insulin delivery—a human touch,” says James White, president and co-founder, Common Sensing. “If an individual is taking the wrong amount of insulin or misses an insulin dose, they will be contacted immediately by a Certified Diabetes Educator (CDE) who can work with the user to resolve the issue. Data-driven, real-time intervention from coaches will set insulin users up for success between doctor visits, improving the health of people living with diabetes.”